Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Gynecology

  Free Subscription


Articles published in Int J Oncol

Retrieve available abstracts of 77 articles:
HTML format
Text format



Single Articles


    June 2018
  1. LIU J, Liu D, Liu JJ, Zhao C, et al
    Blocking the Nav1.5 channel using eicosapentaenoic acid reduces migration and proliferation of ovarian cancer cells.
    Int J Oncol. 2018 Jun 12. doi: 10.3892/ijo.2018.4437.
    PubMed     Text format     Abstract available


  2. MUNGUIA-MORENO JA, Diaz-Chavez J, Garcia-Villa E, Albino-Sanchez ME, et al
    Early synergistic interactions between the HPV16E7 oncoprotein and 17beta-oestradiol for repressing the expression of Granzyme B in a cervical cancer model.
    Int J Oncol. 2018 Jun 6. doi: 10.3892/ijo.2018.4432.
    PubMed     Text format     Abstract available


    May 2018
  3. KANG MA, Kim W, Jo HR, Shin YJ, et al
    Anticancer and radiosensitizing effects of the cyclin-dependent kinase inhibitors, AT7519 and SNS032, on cervical cancer.
    Int J Oncol. 2018 May 31. doi: 10.3892/ijo.2018.4424.
    PubMed     Text format     Abstract available


  4. SONG J, Zhang W, Wang S, Liu K, et al
    A panel of 7 prognosis-related long non-coding RNAs to improve platinum-based chemoresistance prediction in ovarian cancer.
    Int J Oncol. 2018 May 11. doi: 10.3892/ijo.2018.4403.
    PubMed     Text format     Abstract available


  5. SHEN L, Sun B, Sheng J, Yu S, et al
    PGC1alpha promotes cisplatin resistance in human ovarian carcinoma cells through upregulation of mitochondrial biogenesis.
    Int J Oncol. 2018 May 9. doi: 10.3892/ijo.2018.4401.
    PubMed     Text format     Abstract available


    April 2018
  6. QIU C, Wang Y, Wang X, Zhang Q, et al
    Combination of TP53 and AGR3 to distinguish ovarian high-grade serous carcinoma from low-grade serous carcinoma.
    Int J Oncol. 2018 Apr 4. doi: 10.3892/ijo.2018.4360.
    PubMed     Text format     Abstract available


  7. WANG Y, Qiu C, Lu N, Liu Z, et al
    FOXD1 is targeted by miR-30a-5p and miR-200a-5p and suppresses the proliferation of human ovarian carcinoma cells by promoting p21 expression in a p53-independent manner.
    Int J Oncol. 2018 Apr 4. doi: 10.3892/ijo.2018.4359.
    PubMed     Text format     Abstract available


    March 2018
  8. TANG G, Guo J, Zhu Y, Huang Z, et al
    Metformin inhibits ovarian cancer via decreasing H3K27 trimethylation.
    Int J Oncol. 2018 Mar 29. doi: 10.3892/ijo.2018.4343.
    PubMed     Text format     Abstract available


  9. KIM SY, Kwon SK, Lee SY, Baek KH, et al
    Ubiquitin-specific peptidase 5 and ovarian tumor deubiquitinase 6A are differentially expressed in p53+/+ and p53-/- HCT116 cells.
    Int J Oncol. 2018 Mar 5. doi: 10.3892/ijo.2018.4302.
    PubMed     Text format     Abstract available


    February 2018
  10. TIAN R, Li X, Gao Y, Li Y, et al
    Identification and validation of the role of matrix metalloproteinase-1 in cervical cancer.
    Int J Oncol. 2018 Feb 7. doi: 10.3892/ijo.2018.4267.
    PubMed     Text format     Abstract available


  11. YUAN Y, Ye HQ, Ren QC
    Upregulation of the BDNF/TrKB pathway promotes epithelial-mesenchymal transition, as well as the migration and invasion of cervical cancer.
    Int J Oncol. 2018;52:461-472.
    PubMed     Text format     Abstract available


    January 2018
  12. XU M, Xiao J, Chen M, Yuan L, et al
    miR1495p promotes chemotherapeutic resistance in ovarian cancer via the inactivation of the Hippo signaling pathway.
    Int J Oncol. 2018 Jan 24. doi: 10.3892/ijo.2018.4252.
    PubMed     Text format     Abstract available


  13. SATO N, Saga Y, Uchibori R, Tsukahara T, et al
    Eradication of cervical cancer in vivo by an AAV vector that encodes shRNA targeting human papillomavirus type 16 E6/E7.
    Int J Oncol. 2018 Jan 15. doi: 10.3892/ijo.2018.4245.
    PubMed     Text format     Abstract available


  14. WANG Y, Yu X, Song H, Feng D, et al
    The STAT-ROS cycle extends IFNinduced cancer cell apoptosis.
    Int J Oncol. 2018;52:305-313.
    PubMed     Text format     Abstract available


    November 2017
  15. CHANG RK, Li X, Mu N, Hrydziuszko O, et al
    MicroRNA expression profiles in nonepithelial ovarian tumors.
    Int J Oncol. 2017 Nov 10. doi: 10.3892/ijo.2017.4200.
    PubMed     Text format     Abstract available


    October 2017
  16. PENG F, Zhong Y, Liu Y, Zhang Y, et al
    SPARC suppresses lymph node metastasis by regulating the expression of VEGFs in ovarian carcinoma.
    Int J Oncol. 2017 Oct 19. doi: 10.3892/ijo.2017.4168.
    PubMed     Text format     Abstract available


  17. OZRETIC P, Trnski D, Musani V, Maurac I, et al
    Non-canonical Hedgehog signaling activation in ovarian borderline tumors and ovarian carcinomas.
    Int J Oncol. 2017 Oct 12. doi: 10.3892/ijo.2017.4156.
    PubMed     Text format     Abstract available


  18. SHETA R, Bachvarova M, Plante M, Gregoire J, et al
    Altered expression of different GalNActransferases is associated with disease progression and poor prognosis in women with high-grade serous ovarian cancer.
    Int J Oncol. 2017 Oct 9. doi: 10.3892/ijo.2017.4147.
    PubMed     Text format     Abstract available


  19. PAN H, Wang F, Rankin GO, Rojanasakul Y, et al
    Inhibitory effect of black tea pigments, theaflavin3/3'-gallate against cisplatin-resistant ovarian cancer cells by inducing apoptosis and G1 cell cycle arrest.
    Int J Oncol. 2017 Oct 3. doi: 10.3892/ijo.2017.4145.
    PubMed     Text format     Abstract available


  20. GUO J, Cai J, Zhang Y, Zhu Y, et al
    Establishment of two ovarian cancer orthotopic xenograft mouse models for in vivo imaging: A comparative study.
    Int J Oncol. 2017;51:1199-1208.
    PubMed     Text format     Abstract available


  21. LAI Y, Fan L, Zhao Y, Ge H, et al
    Cx32 suppresses extrinsic apoptosis in human cervical cancer cells via the NFkappaB signalling pathway.
    Int J Oncol. 2017;51:1159-1168.
    PubMed     Text format     Abstract available


    September 2017
  22. LIAO S, Xiao S, Chen H, Zhang M, et al
    The receptor for activated protein kinase C promotes cell growth, invasion and migration in cervical cancer.
    Int J Oncol. 2017 Sep 27. doi: 10.3892/ijo.2017.4137.
    PubMed     Text format     Abstract available


  23. BU S, Zhang Q, Wang Q, Lai D, et al
    Human amniotic epithelial cells inhibit growth of epithelial ovarian cancer cells via TGFbeta1-mediated cell cycle arrest.
    Int J Oncol. 2017 Sep 14. doi: 10.3892/ijo.2017.4123.
    PubMed     Text format     Abstract available


    August 2017
  24. QIU JJ, Zhang XD, Tang XY, Zheng TT, et al
    ElncRNA1, a long non-coding RNA that is transcriptionally induced by oestrogen, promotes epithelial ovarian cancer cell proliferation.
    Int J Oncol. 2017;51:507-514.
    PubMed     Text format     Abstract available


    June 2017
  25. RAN X, Zhou P, Zhang K
    Autophagy plays an important role in stemness mediation and the novel dual function of EIG121 in both autophagy and stemness regulation of endometrial carcinoma JEC cells.
    Int J Oncol. 2017 Jun 21. doi: 10.3892/ijo.2017.4047.
    PubMed     Text format     Abstract available


    May 2017
  26. LI X, Jin Y, Mu Z, Chen W, et al
    MicroRNA146a5p enhances cisplatininduced apoptosis in ovarian cancer cells by targeting multiple antiapoptotic genes.
    Int J Oncol. 2017 May 29. doi: 10.3892/ijo.2017.4023.
    PubMed     Text format     Abstract available


  27. SCHREVEL M, Osse EM, Prins FA, Trimbos JBMZ, et al
    Autocrine expression of the epidermal growth factor receptor ligand heparin-binding EGF-like growth factor in cervical cancer.
    Int J Oncol. 2017 May 3. doi: 10.3892/ijo.2017.3980.
    PubMed     Text format     Abstract available


  28. LIU Y, Murray-Stewart T, Casero RA Jr, Kagiampakis I, et al
    Targeting hexokinase 2 inhibition promotes radiosensitization in HPV16 E7-induced cervical cancer and suppresses tumor growth.
    Int J Oncol. 2017 May 2. doi: 10.3892/ijo.2017.3979.
    PubMed     Text format     Abstract available


  29. PALMA FLORES C, Garcia-Vazquez R, Gallardo Rincon D, Ruiz-Garcia E, et al
    MicroRNAs driving invasion and metastasis in ovarian cancer: Opportunities for translational medicine (Review).
    Int J Oncol. 2017;50:1461-1476.
    PubMed     Text format     Abstract available


  30. YANG J, Wang Y, Zeng Z, Qiao L, et al
    Smad4 deletion in blood vessel endothelial cells promotes ovarian cancer metastasis.
    Int J Oncol. 2017;50:1693-1700.
    PubMed     Text format     Abstract available


    April 2017
  31. XU J, Jiang N, Shi H, Zhao S, et al
    [Corrigendum] miR-28-5p promotes the development and progression of ovarian cancer through inhibition of N4BP1.
    Int J Oncol. 2017 Apr 27. doi: 10.3892/ijo.2017.3977.
    PubMed     Text format     Abstract available


  32. PIAO J, You K, Guo Y, Zhang Y, et al
    Substrate stiffness affects epithelial-mesenchymal transition of cervical cancer cells through miR-106b and its target protein DAB2.
    Int J Oncol. 2017 Apr 27. doi: 10.3892/ijo.2017.3978.
    PubMed     Text format     Abstract available


  33. YANOKURA M, Banno K, Adachi M, Aoki D, et al
    Genome-wide DNA methylation sequencing reveals miR-663a is a novel epimutation candidate in CIMP-high endometrial cancer.
    Int J Oncol. 2017 Apr 19. doi: 10.3892/ijo.2017.3966.
    PubMed     Text format     Abstract available


    March 2017
  34. DEVOR EJ, Gonzalez-Bosquet J, Warrier A, Reyes HD, et al
    p53 mutation status is a primary determinant of placenta-specific protein 1 expression in serous ovarian cancers.
    Int J Oncol. 2017 Mar 23. doi: 10.3892/ijo.2017.3931.
    PubMed     Text format     Abstract available


  35. CHANG YS, Huang HD, Yeh KT, Chang JG, et al
    Identification of novel mutations in endometrial cancer patients by whole-exome sequencing.
    Int J Oncol. 2017 Mar 20. doi: 10.3892/ijo.2017.3919.
    PubMed     Text format     Abstract available


  36. XU J, Jiang N, Shi H, Zhao S, et al
    miR-28-5p promotes the development and progression of ovarian cancer through inhibition of N4BP1.
    Int J Oncol. 2017 Mar 16. doi: 10.3892/ijo.2017.3915.
    PubMed     Text format     Abstract available


  37. YOKOYAMA T, Kohn EC, Brill E, Lee JM, et al
    Apoptosis is augmented in high-grade serous ovarian cancer by the combined inhibition of Bcl-2/Bcl-xL and PARP.
    Int J Oncol. 2017 Mar 15. doi: 10.3892/ijo.2017.3914.
    PubMed     Text format     Abstract available


  38. CHA HJ, Choi JH, Park IC, Kim CH, et al
    Selective FGFR inhibitor BGJ398 inhibits phosphorylation of AKT and STAT3 and induces cytotoxicity in sphere-cultured ovarian cancer cells.
    Int J Oncol. 2017 Mar 15. doi: 10.3892/ijo.2017.3913.
    PubMed     Text format     Abstract available


  39. LI J, Li Q, Huang H, Li Y, et al
    Overexpression of miRNA-221 promotes cell proliferation by targeting the apoptotic protease activating factor-1 and indicates a poor prognosis in ovarian cancer.
    Int J Oncol. 2017 Mar 7. doi: 10.3892/ijo.2017.3898.
    PubMed     Text format     Abstract available


  40. SU K, Wang CF, Zhang Y, Cai YJ, et al
    miR-940 upregulation contributes to human cervical cancer progression through p27 and PTEN inhibition.
    Int J Oncol. 2017 Mar 7. doi: 10.3892/ijo.2017.3897.
    PubMed     Text format     Abstract available


  41. WANG Y, Compton C, Rankin GO, Cutler SJ, et al
    3-Hydroxyterphenyllin, a natural fungal metabolite, induces apoptosis and S phase arrest in human ovarian carcinoma cells.
    Int J Oncol. 2017 Mar 2. doi: 10.3892/ijo.2017.3894.
    PubMed     Text format     Abstract available


    February 2017
  42. VERA CA, Orostica L, Gabler F, Ferreira A, et al
    The nerve growth factor alters calreticulin translocation from the endoplasmic reticulum to the cell surface and its signaling pathway in epithelial ovarian cancer cells.
    Int J Oncol. 2017 Feb 28. doi: 10.3892/ijo.2017.3892.
    PubMed     Text format     Abstract available


  43. SATO M, Kawana K, Adachi K, Fujimoto A, et al
    Targeting glutamine metabolism and the focal adhesion kinase additively inhibits the mammalian target of the rapamycin pathway in spheroid cancer stem-like properties of ovarian clear cell carcinoma in vitro.
    Int J Oncol. 2017 Feb 23. doi: 10.3892/ijo.2017.3891.
    PubMed     Text format     Abstract available


  44. WANG S, Meng X, Dong Y
    Ursolic acid nanoparticles inhibit cervical cancer growth in vitro and in vivo via apoptosis induction.
    Int J Oncol. 2017 Feb 22. doi: 10.3892/ijo.2017.3890.
    PubMed     Text format     Abstract available


  45. PARK SH, Chung YJ, Song JY, Kim SI, et al
    Mullerian inhibiting substance inhibits an ovarian cancer cell line via beta-catenin interacting protein deregulation of the Wnt signal pathway.
    Int J Oncol. 2017 Feb 13. doi: 10.3892/ijo.2017.3874.
    PubMed     Text format     Abstract available


  46. ZHU X, Ji M, Han Y, Guo Y, et al
    PGRMC1-dependent autophagy by hyperoside induces apoptosis and sensitizes ovarian cancer cells to cisplatin treatment.
    Int J Oncol. 2017 Feb 10. doi: 10.3892/ijo.2017.3873.
    PubMed     Text format     Abstract available


    January 2017
  47. ZHOU X, Yue Y, Wang R, Gong B, et al
    MicroRNA-145 inhibits tumorigenesis and invasion of cervical cancer stem cells.
    Int J Oncol. 2017 Jan 19. doi: 10.3892/ijo.2017.3857.
    PubMed     Text format     Abstract available


  48. ZHOU G, Peng F, Zhong Y, Chen Y, et al
    Rhein suppresses matrix metalloproteinase production by regulating the Rac1/ROS/MAPK/AP-1 pathway in human ovarian carcinoma cells.
    Int J Oncol. 2017 Jan 17. doi: 10.3892/ijo.2017.3853.
    PubMed     Text format     Abstract available


  49. CHEN C, Wang Y, Wang S, Liu Y, et al
    LSD1 sustains estrogen-driven endometrial carcinoma cell proliferation through the PI3K/AKT pathway via di-demethylating H3K9 of cyclin D1.
    Int J Oncol. 2017 Jan 16. doi: 10.3892/ijo.2017.3849.
    PubMed     Text format     Abstract available


  50. WINSHIP A, Van Sinderen M, Heffernan-Marks A, Dimitriadis E, et al
    Chondroitin sulfate proteoglycan protein is stimulated by interleukin 11 and promotes endometrial epithelial cancer cell proliferation and migration.
    Int J Oncol. 2017 Jan 13. doi: 10.3892/ijo.2017.3848.
    PubMed     Text format     Abstract available


    December 2016
  51. OTTE A, Yang Y, von der Ohe J, Melzer C, et al
    SCCOHT tumors acquire chemoresistance and protection by interacting mesenchymal stroma/stem cells within the tumor microenvironment.
    Int J Oncol. 2016;49:2453-2463.
    PubMed     Text format     Abstract available


    November 2016
  52. ZHANG W, He W, Shi Y, Zhao J, et al
    Aberrant TIMELESS expression is associated with poor clinical survival and lymph node metastasis in early-stage cervical carcinoma.
    Int J Oncol. 2016 Nov 29. doi: 10.3892/ijo.2016.3784.
    PubMed     Text format     Abstract available


  53. FU QR, Song W, Deng YT, Li HL, et al
    ESC-3 induces apoptosis of human ovarian carcinomas through Wnt/beta-catenin and Notch signaling in vitro and in vivo.
    Int J Oncol. 2016 Nov 18. doi: 10.3892/ijo.2016.3773.
    PubMed     Text format     Abstract available


  54. TURCONI G, Scaldaferri D, Fabbri M, Monti L, et al
    RNASET2 silencing affects miRNAs and target gene expression pattern in a human ovarian cancer cell model.
    Int J Oncol. 2016 Nov 9. doi: 10.3892/ijo.2016.3763.
    PubMed     Text format     Abstract available


    October 2016
  55. NARAYANAN R, Kim HN, Narayanan NK, Nargi D, et al
    [Retracted] Epidermal growth factor-stimulated human cervical cancer cell growth is associated with EGFR and cyclin D1 activation, independent of COX-2 expression levels.
    Int J Oncol. 2016 Oct 18. doi: 10.3892/ijo.2016.3737.
    PubMed     Text format     Abstract available


  56. XIE Q, Su J, Jiao B, Shen L, et al
    ABT737 reverses cisplatin resistance by regulating ER-mitochondria Ca2+ signal transduction in human ovarian cancer cells.
    Int J Oncol. 2016 Oct 13. doi: 10.3892/ijo.2016.3733.
    PubMed     Text format     Abstract available


  57. INOUE T, Adachi K, Kawana K, Taguchi A, et al
    Cancer-associated fibroblast suppresses killing activity of natural killer cells through downregulation of poliovirus receptor (PVR/CD155), a ligand of activating NK receptor.
    Int J Oncol. 2016;49:1297-304.
    PubMed     Text format     Abstract available


    September 2016
  58. CHEN WC, Hsu HP, Li CY, Yang YJ, et al
    Cancer stem cell marker CD90 inhibits ovarian cancer formation via beta3 integrin.
    Int J Oncol. 2016 Sep 15. doi: 10.3892/ijo.2016.3691.
    PubMed     Text format     Abstract available


  59. LEE J, An S, Choi YM, Lee J, et al
    Musashi-2 is a novel regulator of paclitaxel sensitivity in ovarian cancer cells.
    Int J Oncol. 2016 Sep 6. doi: 10.3892/ijo.2016.3683.
    PubMed     Text format     Abstract available


  60. NAKAMURA H, Taguchi A, Kawana K, Kawata A, et al
    STAT3 activity regulates sensitivity to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in cervical cancer cells.
    Int J Oncol. 2016 Sep 6. doi: 10.3892/ijo.2016.3681.
    PubMed     Text format     Abstract available


  61. PUVANENTHIRAN S, Essapen S, Seddon AM, Modjtahedi H, et al
    Impact of the putative cancer stem cell markers and growth factor receptor expression on the sensitivity of ovarian cancer cells to treatment with various forms of small molecule tyrosine kinase inhibitors and cytotoxic drugs.
    Int J Oncol. 2016 Sep 5. doi: 10.3892/ijo.2016.3678.
    PubMed     Text format     Abstract available


  62. SUN J, Chu H, Ji J, Huo G, et al
    Long non-coding RNA HOTAIR modulates HLA-G expression by absorbing miR-148a in human cervical cancer.
    Int J Oncol. 2016;49:943-52.
    PubMed     Text format     Abstract available


  63. MASUYAMA H, Nakamura K, Nobumoto E, Hiramatsu Y, et al
    Inhibition of pregnane X receptor pathway contributes to the cell growth inhibition and apoptosis of anticancer agents in ovarian cancer cells.
    Int J Oncol. 2016;49:1211-20.
    PubMed     Text format     Abstract available


    August 2016
  64. TAN ZW, Xie S, Hu SY, Liao T, et al
    Caudatin targets TNFAIP1/NF-kappaB and cytochrome c/caspase signaling to suppress tumor progression in human uterine cancer.
    Int J Oncol. 2016 Aug 19. doi: 10.3892/ijo.2016.3662.
    PubMed     Text format     Abstract available


  65. PENG Z, Wang Q, Zhang Y, He J, et al
    EBP50 interacts with EGFR and regulates EGFR signaling to affect the prognosis of cervical cancer patients.
    Int J Oncol. 2016 Aug 11. doi: 10.3892/ijo.2016.3655.
    PubMed     Text format     Abstract available


  66. WU W, Wang Q, Yin F, Yang Z, et al
    Identification of proteomic and metabolic signatures associated with chemoresistance of human epithelial ovarian cancer.
    Int J Oncol. 2016 Aug 10. doi: 10.3892/ijo.2016.3652.
    PubMed     Text format     Abstract available


  67. GOMEZ-GOMEZ Y, Organista-Nava J, Ocadiz-Delgado R, Garcia-Villa E, et al
    The expression of miR-21 and miR-143 is deregulated by the HPV16 E7 oncoprotein and 17beta-estradiol.
    Int J Oncol. 2016;49:549-58.
    PubMed     Text format     Abstract available


    July 2016
  68. LOPEZ-URRUTIA E, Pedroza-Torres A, Fernandez-Retana J, De Leon DC, et al
    PAX8 is transcribed aberrantly in cervical tumors and derived cell lines due to complex gene rearrangements.
    Int J Oncol. 2016;49:371-80.
    PubMed     Text format     Abstract available


    June 2016
  69. CHEN C, Chang YC, Lan MS, Breslin M, et al
    [Corrigendum] Leptin stimulates ovarian cancer cell growth and inhibits apoptosis by increasing cyclin D1 and Mcl-1 expression via the activation of the MEK/ERK1/2 and PI3K/Akt signaling pathways.
    Int J Oncol. 2016 Jun 6. doi: 10.3892/ijo.2016.3564.
    PubMed     Text format     Abstract available


  70. ESPOSITO G, Gigli S, Seguella L, Nobile N, et al
    Rifaximin, a non-absorbable antibiotic, inhibits the release of pro-angiogenic mediators in colon cancer cells through a pregnane X receptor-dependent pathway.
    Int J Oncol. 2016 Jun 1. doi: 10.3892/ijo.2016.3550.
    PubMed     Text format     Abstract available


  71. XIANG XY, Kang JS, Yang XC, Su J, et al
    SIRT3 participates in glucose metabolism interruption and apoptosis induced by BH3 mimetic S1 in ovarian cancer cells.
    Int J Oncol. 2016 Jun 1. doi: 10.3892/ijo.2016.3552.
    PubMed     Text format     Abstract available


  72. WANG D, Saga Y, Sato N, Nakamura T, et al
    The hepatocyte growth factor antagonist NK4 inhibits indoleamine-2,3-dioxygenase expression via the c-Met-phosphatidylinositol 3-kinase-AKT signaling pathway.
    Int J Oncol. 2016;48:2303-9.
    PubMed     Text format     Abstract available


  73. SUN L, Xia WY, Zhao SH, Liu N, et al
    An asymmetrically dimethylarginated nuclear 90 kDa protein (p90aDMA) induced by interleukin (IL)-2, IL-4 or IL-6 in the tumor microenvironment is selectively degraded by autophagy.
    Int J Oncol. 2016;48:2461-71.
    PubMed     Text format     Abstract available


    May 2016
  74. ROGERS-BROADWAY KR, Chudasama D, Pados G, Tsolakidis D, et al
    Differential effects of rapalogues, dual kinase inhibitors on human ovarian carcinoma cells in vitro.
    Int J Oncol. 2016 May 18. doi: 10.3892/ijo.2016.3531.
    PubMed     Text format     Abstract available


  75. QI X, Du L, Chen X, Chen L, et al
    VEGF-D-enhanced lymph node metastasis of ovarian cancer is reversed by vesicular stomatitis virus matrix protein.
    Int J Oncol. 2016 May 17. doi: 10.3892/ijo.2016.3527.
    PubMed     Text format     Abstract available


  76. FENG S, Yang Y, Lv J, Sun L, et al
    Valproic acid exhibits different cell growth arrest effect in three HPV-positive/negative cervical cancer cells and possibly via inducing Notch1 cleavage and E6 downregulation.
    Int J Oncol. 2016 May 6. doi: 10.3892/ijo.2016.3508.
    PubMed     Text format     Abstract available


    March 2016
  77. AGUILAR-ROJAS A, Perez-Solis MA, Maya-Nunez G
    The gonadotropin-releasing hormone system: Perspectives from reproduction to cancer (Review).
    Int J Oncol. 2016;48:861-8.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Gynecology is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: